Reflections on the Application of Critical Care Ultrasound in Viral Pneumonia Patients with Circulatory Dysfunction—New Classification and Precision Treatment Based on Ciritical Care Ultrasound
Abstract
Viruses are among the main pathogens of pulmonary infection and tend to cause pandemics of viral pneumonia. Severe viral pneumonia tends to be accompanied by acute respiratory distress syndrome (ARDS) manifestations, displaying highly specific clinical symptoms that are most prominently expressed in the circulatory system. Shock occurred rarely, it occured at a rather late stage in this outbreak of viral pneumonia. However, because of the extensive use of critical care ultrasound, we have a deeper understanding of the characteristics of acute circulatory disorder caused by severe viral pneumonia, prompting us to reflect more thoroughly about circulatory disorders caused by other types of infections. In general, acute circulatory disorder is not uncommon in severe viral pneumonia in this outbreak, and is characterized by vascular damage, volume disorder and cardiac abnormalities of three types, high stress state, acute right ventricular dysfunction and diffuse cardiac inhibition. In the case of poor management in the early stage, these acute circulatory disorders may develop into shock, or directly cause or aggravate other organ dysfunction, for example, acute kidney injury, exacerbating the adverse outcomes. This has allowed us to reflect more thoroughly on the occurrence and development of acute circulatory disorders caused by other infections. Therefore, the classification of acute circulatory disorders based on the modular assessment of critical care ultrasound will help promote better understanding of acute circulatory disorders and further research.
Keywords: Viral infection, Acute circulatory dysfunction, Hemodynamics, Critical care ultrasound, Diagnosis, Treatment
Full Text:
PDFReferences
TAUBENBERGER J K, MORENS D M. The 1918 influenza pandemic and its legacy. Cold Spring Harb Perspect Med,2020,10: a038695[2020-12-16]. https://doi.org/10.1101/cshperspect.a038695.
DAWOOD F S, IULIANO A D, REED C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis,2012, 12(9): 687–695.
MALVY D, MCELROY A K, CLERCK H D, et al. Ebola virus disease. Lancet,2019,393(10174): 936–948.
HEATON P M. The Covid-19 vaccine-development multiverse. N Engl J Med,2020,383(20): 1986–1988.
HUANG C L, WANG Y M, LI X W, et al. Clinical features of patients with 2019 novel coronavirus in Wuhan, China. Lancet,2020,395(10223): 497–506.
MALIK Y S, SIRCAR S, BHAT S, et al. Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q,2020,40(1): 68–76.
CHAN K W, WONG V T, TANG S C W. COVID-19: An update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of Integrative Chinese-Western Medicine for the management of 2019 novel coronavirus disease. Am J Chin Med,2020,48(3): 737–762.
CHEN N, ZHOU M, DONG X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet,2020,395(10223): 507–513.
GUAN W J, NI Z Y, HU Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med,2020,382(18): 1708–1720.
PILLINGER N L, KAM P. Endothelial glycocalyx: Basic science and clinical implications. Anaesth Intensive Care,2017,45(3): 295–307.
SOUTH A M, DIZ D I, CHAPPELL M C. COVID-19, AEC2, and the cardiovascular consequences. AM J Physiol Heart Circ Physiol,2020, 318(5): H1084–H1090.
LEVY B, FRITZ C, TAHON E, et al. Vasoplegia treatments: The past, the present, and the future. Crit Care,2018,22(1): 52.
CARSANA L, SONZOGNI A, NASR A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: A two-centre descriptive study. Lancet Infect Dis,2020,20(10): 1135–1140.
PENG Q Y, WANG X T, ZHANG L N, et al. Using echocardiography to guide the treatment of novel coronavirus pneumonia. Crit Care,2020, 24(1): 143.
RAGAB D, ELDIN H S, TAEIMAH M, et al. The COVID-19 cytokine storm; What we know so far. Front Immunol,2020,11: 1446[2021-12-16]. https://doi.org/10.3389/fimmu.2020.01446.
VINCENT J L, DE BACKER D. Circulatory shock. N Engl J Med,2014, 370(6): 583.
Refbacks
- There are currently no refbacks.



